Unlock instant, AI-driven research and patent intelligence for your innovation.

Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same

A technology of olmesartan medoxomil and a synthesis method, which is applied in the field of chemical synthesis, can solve the problems of long synthesis route and increase the difficulty of industrialization, and achieves the effects of simple operation, less side reactions and high yield

Active Publication Date: 2012-07-18
NANTONG SHIMEIKANG PHARMA CHEM
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Shanghai Pharmaceutical Industry Research Institute (CN15321195) reported a new olmesartan intermediate 4,4-dimethyl-2-propyl-4,6-dihydrofuro[3,4-d]imidazole-6 -ketone, when this intermediate is condensed with biphenyl, the generation of isomers is effectively reduced, the condensation yield is improved, and it provides a good choice for the synthesis of olmesartan, but this intermediate is still based on the original 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylic acid ethyl ester is used as the starting material, and the synthetic route is longer, which further increases the difficulty of industrialization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same
  • Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same
  • Olmesartan medoxomil key intermediate, synthesis method thereof and method for synthesizing olmesartan medoxomil from same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1: Preparation of 4,4-dimethyl-2-propyl-4,6-dihydrofuro[3,4-d]imidazole-6-hydroxyl (III).

[0036]Anhydrous tin dichloride (0.03mol) and diethyl ether (100mL) were placed in a three-neck flask equipped with a calcium chloride drying tube condenser and a mechanical stirrer, and dry hydrogen chloride gas was introduced, and the mixed solution was slowly stirred until the solid was completely disappear. After stopping the flow of hydrogen chloride, 4-(1-hydroxy-1-methylethyl)-2-propylimidazol-5-cyano(I) (2.9 g, 0.015 mol) was quickly dropped in and vigorously stirred for 1 h. The mixture was allowed to stand until the solid-liquid separation was complete, the supernatant was poured out, the residue was washed with ether (30ml×2), water (80ml) was added to the remaining solid, and the pH was adjusted to neutral with sodium bicarbonate. The mixture was distilled, and the distillation was stopped when the volume of the distillate was about 50ml. The distillate was ex...

Embodiment 2

[0039] Example 2: Preparation of 4,4-dimethyl-2-propyl-4,6-dihydrofuro[3,4-d]imidazole-6-hydroxyl (III).

[0040] Dissolve 4-(1-hydroxyl-1-methylethyl)-2-propylimidazolium-5-cyanide (I) (2.9g, 0.015mol) in 30ml of anhydrous dichloromethane, N 2 Under protection, DIBAL-H (0.015mol) was slowly added dropwise at room temperature, and the addition was completed in 30 minutes. The solution turned slightly yellow, kept at the temperature for 2h, TLC to no raw material. Add saturated ammonium chloride solution (20ml) dropwise at room temperature. At this time, the solution slowly becomes cloudy. After the addition, continue to stir for 0.5 hours, then add ethyl acetate (30ml) and continue to stir for 1 hour. Separate the organic layer, and wash the aqueous layer with acetic acid Ethyl ester (20ml×2) was extracted, the organic layers were combined, dried over anhydrous magnesium sulfate, filtered, and the organic solvent was spinned out under reduced pressure to obtain a light yellow...

Embodiment 3

[0043] Example 3: Preparation of 4,4-dimethyl-2-propyl-4,6-dihydrofuro[3,4-d]imidazole-6-hydroxyl (III).

[0044] Dissolve 4-(1-hydroxy-1-methylethyl)-2-propylimidazol-5-cyanide (I) (2.9g, 0.015mol) in 50ml of absolute ethanol, add 0.3g of Raney nickel, Add 1ml of formic acid dropwise, and react with hydrogen at normal temperature and pressure until no hydrogen is absorbed. After the reaction was completed, filter, and the oily product 4,4-dimethyl-2-propyl-4,6-dihydrofuro[3,4-d]imidazole-6-hydroxyl (III) was concentrated and dried in the filtrate, and the yield was 79%, the detection parameters are as follows:

[0045] 1 H NMR (300MHz, CDCl 3 +D 2 O) δppm: 0.95 ~ 1.03 (3H, t, CH 3 CH 2 CH 2 ), 1.64~1.76 (6H, s, 2 CH 3 ), 1.83~1.95 (2H, m, CH 3 CH 2 CH 2 ), 2.35~2.55 (2H, m, CH 3 CH 2 CH 2 ).

[0046] MS (FAB, m / z): 195 (M + +1).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an olmesartan medoxomil key intermediate, wherein the structural formula is shown as (III). The invention also discloses a synthesis method of the olmesartan medoxomil key intermediate and a method for synthesizing olmesartan medoxomil from the same. The invention has the advantages of simple and convenient operation method, fewer side effects, more reasonable method and high yield and is suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of chemical synthesis, and in particular relates to a key intermediate of olmesartan medoxomil and a synthesis method thereof and a method for synthesizing olmesartan medoxomil from the intermediate. Background technique [0002] Olmesartan medoxomil was developed by Sankyo, Japan, and its chemical name is 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazole-5 -yl)phenyl]phenyl}methylimidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; English name: Olmesartan Medoxomil, the seventh angiotensin II receptor AT approved by the US FDA for the treatment of hypertension 1 Antagonist (ARB), which is significantly superior to other similar products in terms of overall efficacy in reducing diastolic blood pressure. May 2002 under the trade name Benicar TM Listed in the United States, olmesartan medoxomil is an alternative imidazole drug, which was approved in Germany in August of the same ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D491/048C07D405/14
Inventor 王秀云朱宣华刘一超王俊华
Owner NANTONG SHIMEIKANG PHARMA CHEM